Literature DB >> 8792386

Carbohydrate metabolism in children receiving growth hormone for 5 years. Chronic renal insufficiency compared with growth hormone deficiency, Turner syndrome, and idiopathic short stature. Genentech Collaborative Group.

P Saenger1, K M Attie, J DiMartino-Nardi, R N Fine.   

Abstract

Carbohydrate metabolism was evaluated by fasting and postprandial glucose, insulin, and hemoglobin (Hb)Alc levels in children with chronic renal insufficiency and various other growth disorders treated with growth hormone. Mean fasting and postprandial glucose remained unchanged throughout the 5-year study period in all four study groups. Median fasting insulin levels rose from low-normal levels into the normal range after 5 years of growth hormone. Average fasting insulin level after 5 years was 10 mU/l. Median postprandial insulin values also rose, yet remained within the normal range at the 5-year mark. Mean Hb Alc levels remained within low to middle end of the normal range in the patients with growth hormone deficiency, Turner syndrome, and idiopathic short stature. Mean Hb Alc levels at the 5 years were slightly elevated to 6.3% for the patients with chronic renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792386

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  9 in total

1.  Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency.

Authors:  C Lesage; J Walker; F Landier; P Chatelain; J L Chaussain; P F Bougnères
Journal:  J Pediatr       Date:  1991-07       Impact factor: 4.406

2.  Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome.

Authors:  R G Rosenfeld; J Frane; K M Attie; J A Brasel; S Burstein; J F Cara; S Chernausek; R W Gotlin; J Kuntze; B M Lippe
Journal:  J Pediatr       Date:  1992-07       Impact factor: 4.406

3.  Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts.

Authors:  B Tönshoff; D Haffner; O Mehls; M Dietz; H Ruder; W F Blum; U Heinrich; B Stöver
Journal:  Kidney Int       Date:  1993-07       Impact factor: 10.612

4.  Growth hormone treatment of children with short stature increases insulin secretion but does not impair glucose disposal.

Authors:  J Walker; J L Chaussain; P F Bougnères
Journal:  J Clin Endocrinol Metab       Date:  1989-08       Impact factor: 5.958

5.  Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate.

Authors:  B Tönshoff; C Tönshoff; O Mehls; J Pinkowski; W F Blum; U Heinrich; B Stöver; N Gretz
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

6.  Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy.

Authors:  N J Hopwood; R L Hintz; J M Gertner; K M Attie; A J Johanson; J Baptista; J Kuntze; R M Blizzard; J F Cara; S D Chernausek
Journal:  J Pediatr       Date:  1993-08       Impact factor: 4.406

7.  Recombinant human growth hormone in infants and young children with chronic renal insufficiency. Genentech Collaborative Study Group.

Authors:  R N Fine; K M Attie; J Kuntze; D F Brown; E C Kohaut
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

8.  Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group.

Authors:  R N Fine; E C Kohaut; D Brown; A J Perlman
Journal:  J Pediatr       Date:  1994-03       Impact factor: 4.406

9.  Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children.

Authors:  S L Kaplan; L E Underwood; G P August; J J Bell; S L Blethen; R M Blizzard; D R Brown; T P Foley; R L Hintz; N J Hopwood
Journal:  Lancet       Date:  1986-03-29       Impact factor: 79.321

  9 in total
  2 in total

1.  Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement.

Authors:  John D Mahan; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

Review 2.  Effects of growth hormone on glucose metabolism and insulin resistance in human.

Authors:  Shin-Hye Kim; Mi-Jung Park
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.